Helen B. Ricalde

FDA investigator

Appears on 9 documents from 2003 to 2023, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).

9
Documents on file
4.7
Observations per 483
2003
First seen
2023
Most recent

What they cite most

From 41 observations

Activity by year

2003: 1, 2006: 1, 2014: 1, 2016: 3, 2018: 2, 2023: 1

Where

New York 5 · New Jersey 3 · Virginia 1

Is Helen B. Ricalde coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 CELGENE CORPORATIONJun 16, 2023 · SUMMIT, New Jersey
483 Hunter Holmes McGuire Veterans Affairs Medical CenterJul 10, 2018 · Richmond, Virginia
483 Chartwell Pharmaceuticals Carmel, LLCFeb 28, 2018 · Carmel, New York
483 Form 483 · FEI 3008189622Dec 21, 2016 · Tuckahoe, New York
483 Hi-Tech Pharmacal, an AKORN CompanyJul 15, 2016 · Amityville, New York
483 Asept Pak IncApr 21, 2016 · Malone, New York
483 Sina LLC, dba OncoMed (Onco 360)Aug 22, 2014 · Great Neck, New York

About this profile

What does Helen B. Ricalde inspect?

Helen B. Ricalde appears on 9 documents on file covering 8 sites, mostly in New York.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.67 and 21 CFR 1271.55.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Helen B. Ricalde is dated Jun 16, 2023.